In 2019, Pn. Sudartati, in her 70s, was diagnosed with a meningioma, a type of primary benign tumor originating from the meninges—the protective membranes surrounding the brain and spinal cord. Her tumor was located behind her left eye, occupying a critical space between the eye and the brainstem. The tumor exerted pressure on key structures, including the brainstem, cerebellum, and parts of the cerebrum. Its size and intricate positioning rendered surgical removal unfeasible, as the risks included severe neurological complications or death.
2019年，年逾70的Sudartati女士被诊断出患有脑膜瘤，这是一种起源于脑膜（包围大脑和脊髓的保护膜）的原发性良性肿瘤。她的肿瘤位于左眼后方，占据了眼睛和脑干之间的关键空间。该肿瘤对包括脑干、小脑以及大脑部分区域在内的重要结构造成了压迫。由于其大小和复杂位置，手术切除被认为不可行，因为风险包括严重的神经并发症或死亡。To manage her condition, Pn. Sudartati began treatment with ECCT as Treatment Options for Meningioma to disrupt tumor cell activity by altering their electrical properties, effectively slowing tumor growth. However, due to the tumor's encapsulation by a fibrous membrane, the body's ability to eliminate dead cells was limited, and complete tumor resolution without surgery was unlikely.
为了控制病情，Sudartati女士开始接受ECCT治疗，该疗法通过改变肿瘤细胞的电特性来干扰其活动，从而有效减缓肿瘤生长。然而，由于肿瘤被纤维膜包裹，身体消除死亡细胞的能力受到限制，因此在无手术的情况下完全解决肿瘤是不太可能的。Over the following five years, Pn. Sudartati's tumor showed minimal shrinkage, reducing by a few millimeters. Importantly, the therapy succeeded in halting further tumor growth, ensuring her condition remained stable. While living with an unchanged tumor can be emotionally challenging, Pn. Sudartati embraced the stability it offered, valuing her quality of life and the avoidance of surgical risks.
在接下来的五年中，Sudartati女士的肿瘤仅表现出轻微的缩小，减少了几毫米。重要的是，治疗成功阻止了肿瘤的进一步生长，确保了她的病情保持稳定。虽然与不变的肿瘤共存可能在情感上具有挑战性，但Sudartati女士接受了这种稳定状态，并珍视它为她的生活质量和避免手术风险所带来的益处。Today, after five years of ECCT therapy, Pn. Sudartati continues to live a fulfilling and stable life, free from significant tumor progression. Her journey underscores the value of innovative therapies like ECCT in managing complex, inoperable tumors and the importance of acceptance and resilience in facing such diagnoses.
今天，在接受ECCT治疗五年后，Sudartati女士依然过着充实而稳定的生活，没有出现显著的肿瘤进展。她的经历突显了像ECCT这样的创新疗法在处理复杂且无法手术的肿瘤中的价值，以及面对这种诊断时接受与坚韧的重要性。These experiences demonstrate how personalized treatment approaches can address even the most complex medical challenges, offering hope and improved quality of life for patients and their families.
这些经历展示了个性化治疗方法如何应对最复杂的医学挑战，为患者及其家人带来希望并改善生活质量。
Comentarios